(Q57998180)

Europe PubMed Central

PubMed ID

1831246

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1831246

full work available at URL

4 December 2022

language of work or name

English

0 references

publication date

5 September 1991

0 references

http://content.nejm.org/cgi/content/abstract/325/10/733

online access status

open access

1 reference

Europe PubMed Central

PubMed ID

1831246

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1831246

http://www.nejm.org/doi/pdf/10.1056/NEJM199109053251012

4 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

The New England Journal of Medicine

4 December 2022

published in

0 references

volume

325

0 references

issue

10

0 references

page(s)

733-735

0 references

cites work

High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection

1

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection

4 December 2022

2

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

Antibody response in primary human immunodeficiency virus infection

4 December 2022

4

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

T-cell subset alterations and lymphocyte responsiveness to mitogens and antigen during severe primary infection with HIV: a case series of seven consecutive HIV seroconverters

4 December 2022

5

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

Three-year prospective study of HTLV-III/LAV infection in homosexual men.

4 December 2022

7

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease

4 December 2022

9

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations

4 December 2022

10

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type 1. The Transfusion Safety Study Group

4 December 2022

12

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors--an assessment of the efficacy of testing in donor screening. The HIV-Antigen Study Group

4 December 2022

13

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

Evaluation of screened blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells.

4 December 2022

14

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection

4 December 2022

15

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection

4 December 2022

16

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type 1. The Transfusion Safety Study Group

4 December 2022

17

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

Earlier detection of HIV and second-generation antibody assays

4 December 2022

18

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

Zidovudine in the management of primary HIV-1 infection

4 December 2022

19

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

HIV antigenaemia and virus isolation from plasma during primary HIV infection

4 December 2022

20

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection

4 December 2022

21

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication

4 December 2022

22

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

CD8+ T lymphocyte control of HIV replication in cultured CD4+ cells varies among infected individuals

4 December 2022

23

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

CD8+ lymphocytes suppress HIV production by autologous CD4+ cells without eliminating the infected cells from culture

4 December 2022

24

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual

4 December 2022

25

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

Mysteries of HIV: challenges for therapy and prevention

4 December 2022

26

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

Quantitation of human immunodeficiency virus type 1 in the blood of infected persons

4 December 2022

27

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

Plasma viremia in human immunodeficiency virus infection

4 December 2022

28

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease

4 December 2022

29

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion

4 December 2022

31

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

Three-year prospective study of HTLV-III/LAV infection in homosexual men.

4 December 2022

34

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease

4 December 2022

35

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations

4 December 2022

36

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

Zidovudine in the management of primary HIV-1 infection

4 December 2022

37

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection

4 December 2022

38

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection

4 December 2022

39

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection

4 December 2022

41

1 reference

https://api.crossref.org/works/10.1056/NEJM199109053251012

4 December 2022

Identifiers